Sociedad Americana de Hirudoterapia

Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet — National Institute of Pharmacy and Nutrition

OGYÉI · Hungary · europe

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Hungary's National Institute of Pharmacy and Nutrition — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general EU MDR framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
europe
Country
Hungary
Leech status
unregulated
Last ASH review
2026-05-26

Relevant Regulation Codes

  • Hungarian national implementing legislation for Regulation (EU) 2017/745 (MDR)
  • Hungarian Medicines Act (national pharmaceutical law)

Prescriber Requirements

  • Hungarian-licensed physician (orvos) registered with the Hungarian Medical Chamber — order required for any device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Distributors operate under EU MDR Article 14 economic-operator obligations; standard cold-chain conditions for live invertebrates. Hungarian-language IFU.

Import/Export Rules

Intra-EU free circulation as per Regulation (EU) 2017/745. Third-country imports require CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Not covered under public insurance schemes for leech therapy specifically.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Hungary harmonises with EU MDR through national implementing acts; OGYÉI is the competent authority for both pharmaceuticals and many device categories.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.